By Jon Fleetwood
New report confirms U.S. plan to create a synthetic “universal vaccine” using molecular chimeras—engineered mashups of viral pieces—with influenza at the core.
The U.S. Government Accountability Office (GAO) has quietly confirmed the federal government’s plans to launch clinical trials for a “universal vaccine” in 2026—a synthetic injection built by fusing together parts of multiple virus strains into a single dose.
While this Frankenstein-style injection is being marketed as a tool to stop future pandemics, the virus at the center of it all is influenza—the same virus the U.S. government has spent years manipulating through gain-of-function research and now claims is on the verge of causing the next global outbreak.
“Since 2015, most clinical work on universal vaccines has focused on the flu,” the GAO states in its May 2025 Science & Tech Spotlight report. “Multiple universal vaccine candidates targeting the flu… have reached clinical trials.”
This aligns with what we’ve already exposed: Federal agencies have been conducting bird flu gain-of-function experiments for over a decade, pushing mRNA and DNA vaccines for poultry, and stockpiling antiviral contracts—all while whispering warnings about H5N1 jumping to humans.
The Trump administration recently announced the development of a $500 million “next-generation, universal vaccine platform” called ‘Generation Gold Standard’ that will focus on avian influenza “bird flu” jab creation.
Led by Obama-nominated Comptroller General Gene Dodaro, GAO is now confirming another next step in that orchestrated rollout: a universal flu vaccine that doesn’t just target one strain—but uses recombined fragments from many strains at once.
“Scientists can now fuse together microscopic pieces of many different virus strains, increasing the number of strains that can be targeted in a single dose,” the GAO report explains.
This isn’t a new flu shot. It’s a molecular chimera—a biotech construct made from the stitched-together parts of viruses that don’t exist naturally.
Chimeric Engineering Pushed by NIH, HHS, and the Department of Defense
GAO confirms that the Department of Health and Human Services (HHS) and National Institutes of Health (NIH) will begin trials of this fused-fragment platform in 2026, explicitly calling it a “Next-generation, universal vaccine platform.”
And it’s not just HHS and NIH. The Department of Defense is also involved—raising serious questions about biodefense objectives and dual-use risks.
Read the full article in the July/August issue of Rounder Magazine. Preorder now!
This article is republished with permission. It appeared first on JohFleetwood.com under the title ‘GAO Backs ‘Universal Vaccine’ Built From Multiple Virus Fragments Fused Into One—Influenza Takes Center Stage Again.‘
Jon Fleetwood is an investigative journalist, peer-reviewed author, and founder of JonFleetwood.com, exposing weaponized health and political narratives. His body of work—including a peer-reviewed study on early and late-stage COVID-19 treatment with budesonide, published in The Gazette of Medical Sciences—has earned recognition from outlets like Children’s Health Defense, InfoWars, and One America News.
Lead image by jittawit.
